Pharmacy Investment Opportunity in New Delhi, India
Trader and exporter of high-end antibiotic and cancer treatment medicines with 6 brands.
| Established | 1-5 year(s) |
| Employees | 2 - 5 |
| Legal Entity | Sole Proprietorship/Sole Trader |
| Reported Sales | USD 53 thousand |
| Run Rate Sales | USD 70 thousand |
| EBITDA Margin | 10 - 20 % |
| Industries | Pharmacies + 1 more |
| Locations | New Delhi |
| Local Time | 12:27 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
58 thousand
for
40.0%
stake
(Native Currency: INR 5,000,000)
Reason: We are seeking funds to further expand the business by investing in marketing our services.
We also...
View More
Includes physical assets worth
USD
6.4 thousand
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview
- Our primary focus is on providing high-end antibiotics and anti-cancer/cancer therapy medications. We also handle medications used to treat heart arrest, kidney and nephropathy, HIV, hepatitis, and transplants, among other conditions.
- The majority of sales (80%) are through India Mart, with the remaining sales occurring via the company's website and through direct sales to doctors, hospitals, and chemists.
- The business also engages in exports to China, Nigeria, Hong Kong, and the Netherlands.
- It has partnerships with two manufacturing companies and deals with 6-7 brands, including Intas, Concord Biotech, Zydus, Bharat Serum, and Glemark.
- The company holds the necessary drug licenses to operate and is anticipating higher revenue of 60-70 lakh this year.
- This increase in revenue is attributed to planned investments in marketing and customer acquisition.
- The business is able to generate such high sales with only 3 employees due to the margins typically found in the pharmaceutical industry.
- There are 2 permanent employees that take care of order fulfillment and another part-time worker for loading of products and courier service.
- The majority of sales (80%) are through India Mart, with the remaining sales occurring via the company's website and through direct sales to doctors, hospitals, and chemists.
- The business also engages in exports to China, Nigeria, Hong Kong, and the Netherlands.
- It has partnerships with two manufacturing companies and deals with 6-7 brands, including Intas, Concord Biotech, Zydus, Bharat Serum, and Glemark.
- The company holds the necessary drug licenses to operate and is anticipating higher revenue of 60-70 lakh this year.
- This increase in revenue is attributed to planned investments in marketing and customer acquisition.
- The business is able to generate such high sales with only 3 employees due to the margins typically found in the pharmaceutical industry.
- There are 2 permanent employees that take care of order fulfillment and another part-time worker for loading of products and courier service.
Products & Services Overview
The business primarily deals in the supply of high-end critical care medicines and injectables, with the highest-selling products being:- Mofecon 500 tablets.
- Mycofit S 360 tablets.
- Lonopin 40 mg injection.
- Picasa Gr 100 tab.
- Vorier tab.
- Renocrit 4k injection.
- Imat 400 tab.
- Sovihep v tab.
- T planin 200mg injection.
Assets Overview
The main component of the tangible assets is the stocks worth INR 5 lakhs.The other assets include equipment in the store like fridge, table, systems and AC.
Facilities Overview
The store is set up in Khanpur, New Delhi and has a total area of 220 Sq ft.The rent paid is INR 12,000 per month.
Capitalization Overview
The business has one owner and there are no loans or liabilities as a part of it.
Recent Activity
-
Earlier than 15 daysAdvisor, Manufacturing & Marketing Of Chemicals, Gurgaon, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Healthtech, New Delhi, Corporate Investor / Buyer connected with the Business
Tags:
Import / Export Business Investment Opportunity in New Delhi, India
·Medical Agency Investment Opportunity in New Delhi, India
·Medicine Store Investment Opportunity in New Delhi, India
·Medical Shop Investment Opportunity in New Delhi, India
·Invest in Import / Export Business in New Delhi, India
·Pharmacy Investment Opportunity in New Delhi, India
·Import / Export Business Investment Opportunity
·Invest in Medical Agency in New Delhi, India
·Invest in Medicine Store in New Delhi, India
·Investment Opportunity in New Delhi, India
·Invest in Medical Shop in New Delhi, India
·Invest in Pharmacy in New Delhi, India
·Medical Agency Investment Opportunity
·Medicine Store Investment Opportunity
·Medical Shop Investment Opportunity
·Invest in Import / Export Business
·Pharmacy Investment Opportunity
·Invest in New Delhi, India
·Invest in Medical Agency
·Invest in Medicine Store
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
3 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 122,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses